These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 27322816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia.
    Fedders H, Alsadeq A, Schmäh J, Vogiatzi F, Zimmermann M, Möricke A, Lenk L, Stadt UZ, Horstmann MA, Pieters R, Schrappe M, Stanulla M, Cario G, Schewe DM.
    Haematologica; 2017 Nov; 102(11):e438-e442. PubMed ID: 28838992
    [No Abstract] [Full Text] [Related]

  • 3. MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations.
    Kerstjens M, Driessen EM, Willekes M, Pinhanços SS, Schneider P, Pieters R, Stam RW.
    Oncotarget; 2017 Feb 28; 8(9):14835-14846. PubMed ID: 27588400
    [Abstract] [Full Text] [Related]

  • 4. The role of RAS mutations in MLL-rearranged leukaemia: A path to intervention?
    Mansur MB, Ford AM, Emerenciano M.
    Biochim Biophys Acta Rev Cancer; 2017 Dec 28; 1868(2):521-526. PubMed ID: 29056538
    [Abstract] [Full Text] [Related]

  • 5. Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo.
    Kerstjens M, Pinhancos SS, Castro PG, Schneider P, Wander P, Pieters R, Stam RW.
    Haematologica; 2018 Apr 28; 103(4):e147-e150. PubMed ID: 29419436
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.
    Stam RW, Schneider P, de Lorenzo P, Valsecchi MG, den Boer ML, Pieters R.
    Blood; 2007 Oct 01; 110(7):2774-5. PubMed ID: 17881645
    [No Abstract] [Full Text] [Related]

  • 7. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia.
    Emerenciano M, Barbosa Tda C, de Almeida Lopes B, Meyer C, Marschalek R, Pombo-de-Oliveira MS.
    Br J Haematol; 2015 Jul 01; 170(2):268-71. PubMed ID: 25613690
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.
    Stam RW, den Boer ML, Schneider P, Meier M, Beverloo HB, Pieters R.
    Haematologica; 2007 Nov 01; 92(11):1565-8. PubMed ID: 18024407
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW.
    Haematologica; 2013 Jun 01; 98(6):937-44. PubMed ID: 23403319
    [Abstract] [Full Text] [Related]

  • 13. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
    Stumpel DJ, Schneider P, Pieters R, Stam RW.
    Eur J Cancer; 2015 Sep 01; 51(14):2008-21. PubMed ID: 26188848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia.
    Zhu Y, He X, Lin YC, Dong H, Zhang L, Chen X, Wang Z, Shen Y, Li M, Wang H, Sun J, Nguyen LX, Zhang H, Jiang W, Yang Y, Chen J, Müschen M, Chen CW, Konopleva MY, Sun W, Jin J, Carlesso N, Marcucci G, Luo Y, Li L.
    Blood; 2019 Oct 10; 134(15):1257-1268. PubMed ID: 31395602
    [Abstract] [Full Text] [Related]

  • 16. Clinical and molecular epidemiology of neonatal leukemia in Brazil.
    Moura SV, Andrade F, Magalhães IQ, Costa I, Silva DB, D'Andrea ML, Pinheiro VP, Lee ML, Werneck F, Emerenciano M, Pombo-de-Oliveira MS.
    Leuk Lymphoma; 2015 Apr 10; 56(4):903-9. PubMed ID: 24991719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential expression of Ikaros isoforms in monozygotic twins with MLL-rearranged precursor-B acute lymphoblastic leukemia.
    Russell T, Oliver JM, Wilson BS, Tarleton CA, Winter SS, Meng X.
    J Pediatr Hematol Oncol; 2008 Dec 10; 30(12):941-4. PubMed ID: 19131787
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.